Effects of IL-1 receptor-associated kinase-4 gene silencing on human osteoblast-like cells

Connective Tissue Research

Volumn 53, Issue 6, 2012, Pages 498-507

  Yang, Zibo ^a   Huang, Baoding ^a   Zhang, Zhiqi ^a   Kang, Yan ^a   Fu, Ming ^a   Liao, Weiming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

cell function; human osteoblast like cells; IRAK 4; MG63 cells; siRNA

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOBLAST; PROTEIN EXPRESSION; RNA SEQUENCE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; CELL PROLIFERATION; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE 7; MAP KINASE SIGNALING SYSTEM; OSTEOBLASTS;

EID: 84869849654     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2012.694927     Document Type: Article

References (52)

1. Hansson, G.K., and Edfeldt, K. (2005). Toll to be paid at the gateway to the vessel wall. Arterioscler. Thromb. Vasc. Biol. 25:1085-1087.
2. Blasius, A.L., and Beutler, B. (2010). Intracellular toll-like receptors. Immunity 32:305-315.
3. Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
4. Qin, L., Li,G.,Qian, X., Liu, Y.,Wu, X., Liu, B.,Hong, J.S., and Block, M.L. (2005). Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52:78-84.
5. Akira, S., Hoshino, K., and Kaisho, T. (2000). The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin. Res. 6:383-387.
6. Kaisho, T., Hoshino, K., Iwabe, T., Takeuchi, O., Yasui, T., and Akira, S. (2002). Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 14:695-700.
7. Li, S., Strelow, A., Fontana, E.J., and Wesche, H. (2002). IRAK-4:A novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. U.S.A. 99:5567-5572.
8. O'Neill, L.A., and Greene, C. (1998). Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63:650-657.
9. Janssens, S., and Beyaert, R. (2003). Functional diversity and regulation of different Interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 2:293-302.
10. Suzuki, N., Suzuki, S., Eriksson, U., Hara, H., Mirtosis, C., Chen, N.J., Wada, T., Bouchard, D., Hwang, I., Takeda, K., Fujita, T., Der, S., Penninger, J.M., Akira, S., Saito, T., and Yeh, W.C. (2003). IL-1Rassociated kinase 4 is required for lipopolysaccharide- induced activation of APC[J]. J. Immunol. 171:6065-6071.
11. Song, K.W., Talamas, F.X., Suttmann, R.T., Olson, P.S., Barnett, J.W., Lee, S.W., Thompson, K.D., Jin, S., Hekmat-Nejad, M., Cai, T.Z., Manning, A.M., Hill, R.J., and Wong, B.R. (2009). The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells. Mol. Immunol. 2974:1-9.
12. Hall, M.J., and Owings, M.F. (2002). 2000 National hospital discharge survey. Adv. Data 329:1-18.
13. Kurtz, S., Ong, K., Lau, E., Mowat, F., and Halpern, M. (2007). Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89(4):780-785.
14. Berry, D.J., Harmsen, W.S., Cabanela, M.E., and Morrey, B.F. (2002). Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors affecting survivorship of acetabular and femoral components. J. Bone Joint Surg. Am. 84(2):171-177.
15. Keener, J.D., Callaghan, J.J., Goetz, D.D., Pederson, D.R., Sullivan, P.M., and Johnston, R.C. (2003). Twenty-five-year results after Charnley total hip arthroplasty in patients less than fifty years old: A concise follow-up of a previous report. J Bone Joint Surg. Am. 85-A(6):1066-1072.
16. Bauer, T.W. (2002). Particles and periimplant bone resorption. Clin. Orthop. Relat. Res. 405:138-143.
17. Yang, S.Y., Zhang, K., Bai, L., Song, Z., Yu, H., McQueen, D.A., and Wooley, P.H. (2011). Polymethylmethacrylate and titanium alloy particles activate peripheral monocytes during periprosthetic inflammation and osteolysis. J. Orthop. Res. 29(5):781-786.
18. Lye, E., Mirtsos, C., Suzuki, N., Suzuki, S., and Yeh, W.C. (2004). The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 279(39):40653-40658.
19. Kyo, F., Futani, H.,Matsui, K., Terada, M.,Adachi, K.,Nagata, K., Sano, H., Tateishi, H., Tsutsui, H., and Nakanishi, K. (2005). Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in mice. Arthritis Rheum. 52(8):2530-2540.
20. Kwan, T.S., Padrines, M., Théoleyre, S., Heymann, D., and Fortun, Y. (2004). IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15:49-60.
21. Stashenko, P.,Dewhirst, F.E., Peros,W.J., Kent, R.L., and Ago, J.M. (1987). Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J. Immunol. 138:1464-1468.
22. Thomson, B.M., Mundy, G.R., and Chambers, T.J. (1987). Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138:775-779.
23. Yamaguchi, A., Komori, T., and Suda, T. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21:393-411.
24. Dinarello, C.A. (1994). The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314-1315.
25. Olmedo, M.L., Landry, P.S., Sadasivan, K.K., Albright, J.A., Meek, W.D., Routh, R., and Marino, A.A. (1999). Regulation of osteoblast levels during bone healing. J. Orthop. Trauma 13:356-362.
26. Gowen, M., Nedwin, G.E., and Mundy, G.R. (1985). Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J. Clin. Invest. 75:1223-1229.
27. Ikeda, E., Kusaka, M., Hakeda, Y., Yokota, K., Kumegawa, M., and Yamamoto, S. (1988). Effect of interleukin 1 beta on osteoblastic clone MC3T3-E1 cells. Calcif. Tissue Int. 43:162-166.
28. Shen, V., Cheng, S.L., Kohler, N.G., and Peck, W.A. (1990). Characterization and hormonal modulation of IL-1 binding in neonatal mouse osteoblast-like cells. J. Bone Miner. Res. 5:507-515.
29. Zhao, G., Raines, A.L., Wieland, M., Schwartz, Z., and Boyan, B.D. (2007). Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. Biomaterials 28:2821-2829.
30. Milona, M.A., Gough, J.E., and Edgar, A.J. (2003). Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells. BMC Genomics 4:43.
31. Schwartz, Z., Bell, B.F., Wang, L., Zhao, G., Olivares-Navarrete, R., and Boyan, B.D. (2007). Beta-1 integrins mediate substrate dependent effects of 1alpha, 25(OH)2D3 on osteoblasts. J. Steroid Biochem. Mol. Biol. 103:606-609.
32. Pedrazzoni, M., Alfano, F.S., Girasole, G., Giuliani, N., Fantuzzi, M., Gatti, C., Campanini, C., and Passeri, M. (1996). Clinical observations with a new specific assay for bone alkaline phosphatase: A crosssectional study in osteoporosis and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates. Calcif. Tissue Int. 59:334-338.
33. Lincks, J., Boyan, B.D., Blanchard, C.R., Lohmann, C.H., Liu, Y., Cochran, D.L., Dean, D.D., and Schwartz, Z. (1998). Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19:2219-2232.
34. Tang, L.Q., Gong, M.Z., Liu, Z.H., Si, H.P., Xing, D.G., and Zhao, J.J. (2006). Change of osteocalcin in rats with diabetes after fractures. Chi. J. Exp. Surg. 23:617-618.
35. Weaver, C.M., Peacock, M., Martin, B.R., McCabe, G.P., Zhao, J., Smith, D.L., and Wastney, M.E. (1997). Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. J. Bone Miner. Res. 12:1714-1720.
36. Conus, S., Kaufmann, T., Fellay, I., Otter, I., Rossé, T., and Borner, C. (2000). Bcl-2 is a monomeric protein: Prevention of homodimerization by structural constraints. EMBO J. 19:1534-1544.
37. Webb, S.J., Harrison, D.J., and Wyllie, A.H. (1997). Apoptosis: An overview of the process and its relevance in disease. Adv. Pharmacol. 41:1-34.
38. Cui, Y.F., Xia, G.W., Fu, X.B., Yang, H., Peng, R.Y., Zhang, Y., Gu, Q.Y., Gao, Y.B., Cui, X.M., and Hu, W.H. (2003). Relationship between expression of Bax and Bcl-2 proteins and apoptosis in radiation compound wound healing of rats. Chin. J. Traumatol. 6:135-138.
39. Harrison, J.C., Zyla, T.R., Bardes, E.S., and Lew, D.J. (2004). Stressspecific activation mechanisms for the "cell integrity" MAPK pathway. Biol. Chem. 279:2616-2622.
40. Johnson, G.L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
41. Hipskind, R.A., and Bilbe, G. (1998).MAPkinase signaling cascades and gene expression in osteoblasts. Front. Biosci. 3:d804-d816.
42. Lai, C.F., Chaudhary, L., Fausto, A., Halstead, L.R., Ory, D.S., Avioli, L.V., and Cheng, S.L. (2001). Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J. Biol. Chem. 276:14443-14450.
43. Suzuki, A., Guicheux, J., Palmer, G., Miura, Y., Oiso, Y., Bonjour, J.P., and Caverzasio, J. (2002). Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30:91-98.
44. Koziczak-Holbro, M., Littlewood-Evans, A., Pöllinger, B., Kovarik, J., Dawson, J., Zenke, G., Burkhart, C., Müller, M., and Gram, H. (2009). The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation. Arthritis Rheum. 60 (6):1661-1671.
45. Li, X. (2008). IRAK4 in TLR/IL-1R signaling: Possible clinical applications. Eur. J. Immunol. 38(3):614-618.
46. Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., Penninger, J.M., Wesche, H., Ohashi, P.S., Mak, T.W., and Yeh, W.C. (2002). Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 416:750-756.
47. Ding, J., Ghali, O., Lencel, P., Broux, O., Chauveau, C., Devedjian, J.C., Hardouin, P., and Magne, D. (2009). TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 84(15-16):499-504.
48. Komatsu, D.E., Bosch-Marce, M., Semenza, G.L., and Hadjiargyrou, M. (2007). Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency. J. Bone Miner. Res. 22 (3):366-374.
49. Street, J., and Lenehan, B. (2009). Vascular endothelial growth factor regulates osteoblast survival - Evidence for an autocrine feedback mechanism. J. Orthop. Surg. Res. 16(4):19.
50. Bae, S., Siu, P.M., Choudhury, S., Ke, Q., Choi, J.H., Koh, Y.Y., and Kang, P.M. (2010). Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. Am. J. Physiol. Heart Circ. Physiol. 299(5):H1374-H1381.
51. Guicheux, J., Lemonnier, J., Ghayor, C., Suzuki, A., Palmer, G., and Caverzasio, J. (2003). Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18(11):2060-2068.
52. Pautke, C., Schieker, M., Tischer, T., Kolk, A., Neth, P., Mutschler, W., and Milz, S. (2004). Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res. 24(6):3743-3748.